Werewolf Therapeutics (HOWL) Analyst & Key Data

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

8

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.98

Median Target+1.83%

$1.00

Potential upside vs current price

DCF Value+4.11%

$1.02

Potential upside vs current price

Current Stock Price

$0.98

Median Target+1.83%

$1.00

Potential upside vs current price

DCF Value+4.11%

$1.02

Potential upside vs current price

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

8

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.98

Median Target+1.83%

$1.00

Potential upside vs current price

DCF Value+4.11%

$1.02

Potential upside vs current price

Current Stock Price

$0.98

Median Target+1.83%

$1.00

Potential upside vs current price

DCF Value+4.11%

$1.02

Potential upside vs current price

Werewolf Therapeutics, Inc.